Eip Pharma Inc
Clinical trials sponsored by Eip Pharma Inc, explained in plain language.
-
Could a new pill help slow lewy body dementia?
Disease control CompletedThis study tested an experimental drug called neflamapimod in 159 people with dementia with Lewy bodies (DLB), a brain disease that affects memory, movement, and thinking. The goal was to see if the drug could improve learning, problem-solving, and memory compared to a placebo. P…
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Experimental drug shows promise for lewy body dementia
Symptom relief CompletedThis study tested an experimental drug called neflamapimod in 26 people with dementia with Lewy bodies (DLB). The main goal was to check if the drug is safe and how it behaves in the body. Researchers also looked at whether it might help with thinking and memory, but this was a s…
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC